{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:12:28Z","timestamp":1759637548901,"version":"3.32.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.neuropharm.2006.10.007","type":"journal-article","created":{"date-parts":[[2006,11,29]],"date-time":"2006-11-29T21:26:52Z","timestamp":1164835612000},"page":"895-903","source":"Crossref","is-referenced-by-count":13,"title":["Pharmacological and genetic manipulation of kappa opioid receptors: Effects on cocaine- and pentylenetetrazol-induced convulsions and seizure kindling"],"prefix":"10.1016","volume":"52","author":[{"given":"Rafal M.","family":"Kaminski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey M.","family":"Witkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toni S.","family":"Shippenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2006.10.007_bib1","first-page":"620","article-title":"Modification of kindled amygdaloid seizures by opiate agonists and antagonists","volume":"228","author":"Albertson","year":"1984","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib2","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0022-3565(24)37305-7","article-title":"Administered and endogenously released kappa opioids decrease pilocarpine-induced seizures and seizure-induced histopathology","volume":"284","author":"Bausch","year":"1998","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0006-8993(99)01189-0","article-title":"Effects of enadoline on the development of pentylenetetrazol kindling, learning performance, and hippocampal morphology","volume":"823","author":"Becker","year":"1999","journal-title":"Brain Research"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib4","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0196-9781(97)00182-4","article-title":"Naltrexone, naltrindole, and CTOP block cocaine-induced sensitization to seizures and death","volume":"18","author":"Braida","year":"1997","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF02245071","article-title":"Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappa-opioid agonists in the mouse writhing assay","volume":"115","author":"Broadbear","year":"1994","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib6","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0022-3565(24)37419-1","article-title":"Kappa-Opioid receptor binding populations in rhesus monkey brain: relationship to an assay of thermal antinociception","volume":"285","author":"Butelman","year":"1998","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib7","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/0024-3205(92)90515-Q","article-title":"Antagonism of kainic acid lesions in the mouse hippocampus by U-54494A and U-50488H","volume":"51","author":"Camacho Ochoa","year":"1992","journal-title":"Life Sciences"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1126\/science.6120570","article-title":"Dynorphin is a specific endogenous ligand of the kappa opioid receptor","volume":"215","author":"Chavkin","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib9","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0306-4522(00)00417-6","article-title":"Kappa-opioid receptor activation prevents alterations in mesocortical dopamine neurotransmission that occur during abstinence from cocaine","volume":"101","author":"Chefer","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib10","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.1523\/JNEUROSCI.0854-05.2005","article-title":"Endogenous kappa-opioid receptor systems regulate mesoaccumbal dopamine dynamics and vulnerability to cocaine","volume":"25","author":"Chefer","year":"2005","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib11","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1476-5381.1977.tb07532.x","article-title":"Agonist and antagonist properties of buprenorphine: a new antinociceptive agent","volume":"60","author":"Cowan","year":"1977","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib12","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0196-0644(89)80111-8","article-title":"Emergency department presentation of cocaine intoxication","volume":"18","author":"Derlet","year":"1989","journal-title":"Annals of Emergency Medicine"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00000441-199203000-00006","article-title":"The effect of morphine and naloxone on cocaine toxicity","volume":"303","author":"Derlet","year":"1992","journal-title":"American Journal of The Medical Sciences"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib14","first-page":"621","article-title":"Epileptogenic properties of cocaine in humans","volume":"12","author":"Dhuna","year":"1991","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib15","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1528-1157.1991.tb05547.x","article-title":"Chronic, habitual cocaine abuse and kindling-induced epilepsy: a case report","volume":"32","author":"Dhuna","year":"1991","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib16","first-page":"163","article-title":"Anticonvulsant and related effects of U-54494A in various seizure tests","volume":"267","author":"Fischer","year":"1993","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib17","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0022-3565(24)36837-5","article-title":"Anticonvulsant and behavioral effects of neuroactive steroids alone and in conjunction with diazepam","volume":"282","author":"Gasior","year":"1997","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/(SICI)1098-2299(199805)44:1<21::AID-DDR4>3.0.CO;2-R","article-title":"Antiepileptogenic effects of the novel synthetic neuroactive steroid, ganaxolone, against pentylenetetrazol-induced kindled seizures: Comparison with diazepam and valproate","volume":"44","author":"Gasior","year":"1998","journal-title":"Drug Development Research"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0006-8993(93)90228-F","article-title":"The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat","volume":"616","author":"Heidbreder","year":"1993","journal-title":"Brain Research"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib20","first-page":"150","article-title":"Development of behavioral sensitization to cocaine: influence of kappa opioid receptor agonists","volume":"275","author":"Heidbreder","year":"1995","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib21","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0006-8993(00)02776-1","article-title":"Improgan, a cimetidine analog, induces morphine-like antinociception in opioid receptor-knock-out mice","volume":"880","author":"Hough","year":"2000","journal-title":"Brain Research"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib22","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0022-3565(24)29466-0","article-title":"Pentylenetetrazole-induced inhibition of recombinant gamma-aminobutyric acid type A (GABA(A)) receptors: mechanism and site of action","volume":"298","author":"Huang","year":"2001","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0014-2999(03)02086-7","article-title":"Protective efficacy of neuroactive steroids against cocaine kindled-seizures in mice","volume":"474","author":"Kaminski","year":"2003","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neulet.2005.02.056","article-title":"Genetic deletion of the norepinephrine transporter decreases vulnerability to seizures","volume":"382","author":"Kaminski","year":"2005","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s002130051165","article-title":"Cocaine-opioid interactions in groups of rats trained to discriminate different doses of cocaine","volume":"147","author":"Kantak","year":"1999","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib26","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0024-3205(89)90045-3","article-title":"Blockade of \u201creverse tolerance\u201d to cocaine and amphetamine by MK-801","volume":"45","author":"Karler","year":"1989","journal-title":"Life Sciences"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib27","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1528-1157.1996.tb00041.x","article-title":"Relation of cocaine use to seizures and epilepsy","volume":"37","author":"Koppel","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0014-2999(85)90431-5","article-title":"[3H]U-69593 a highly selective ligand for the opioid kappa receptor","volume":"109","author":"Lahti","year":"1985","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib29","first-page":"57","article-title":"Neurochemical and pharmacological aspects of cocaine-induced seizures","volume":"53","author":"Lason","year":"2001","journal-title":"Polish Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib30","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/0028-3908(87)90112-2","article-title":"Buprenorphine has potent kappa opioid receptor antagonist activity","volume":"26","author":"Leander","year":"1987","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib31","first-page":"99","article-title":"A simplified method of evaluating dose-effect experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0920-1211(91)90062-K","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models","volume":"8","author":"L\u00f6scher","year":"1991","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib33","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1152\/jn.1999.82.4.1768","article-title":"Dynorphin selectively augments the M-current in hippocampal CA1 neurons by an opiate receptor mechanism","volume":"82","author":"Madamba","year":"1999","journal-title":"Journal of Neurophysiology"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0091-3057(03)00218-1","article-title":"Studies on the anticonvulsant effect of U50488H on maximal electroshock seizure in mice","volume":"76","author":"Manocha","year":"2003","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0304-3940(02)00847-9","article-title":"Anticonvulsant effects of four neuropeptides in the rat hippocampus during self-sustaining status epilepticus","volume":"331","author":"Mazarati","year":"2002","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib36","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1749-6632.2000.tb06678.x","article-title":"Interactions between kappa opioid agonists and cocaine. Preclinical studies","volume":"909","author":"Mello","year":"2000","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib37","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s002130050027","article-title":"Pharmacological and behavioral characterization of cocaine-kindled seizures in mice","volume":"148","author":"Miller","year":"2000","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0014-2999(97)01090-X","article-title":"Naltrindole, a selective delta-opioid receptor antagonist, potentiates the lethal effects of cocaine by a central mechanism of action","volume":"333","author":"Patterson","year":"1997","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib39","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0024-3205(83)90573-8","article-title":"The effect of various opiate receptor agonists on the seizure threshold in the rat. Is dynorphin an endogenous anticonvulsant?","author":"Przewlocka","year":"1983","journal-title":"Life Sciences 33 (Suppl. 1)"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib40","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0924-977X(94)90302-6","article-title":"Kappa opioid receptor agonists inhibit the pilocarpine-induced seizures and toxicity in the mouse","volume":"4","author":"Przewlocka","year":"1994","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib41","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1046\/j.1471-4159.1998.70020626.x","article-title":"Kappa receptor activation attenuates L-trans-pyrrolidine-2,4-dicarboxylic acid-evoked glutamate levels in the striatum","volume":"70","author":"Rawls","year":"1998","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib42","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1006\/exnr.1996.6368","article-title":"Differential spatial patterns of Fos induction following generalized clonic and generalized tonic seizures","volume":"143","author":"Samoriski","year":"1997","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib43","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s002130051016","article-title":"U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking","volume":"144","author":"Schenk","year":"1999","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib44","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0893-133X(00)00190-1","article-title":"Effects of the kappa-opioid receptor agonist, U69593, on the development of sensitization and on the maintenance of cocaine self-administration","volume":"24","author":"Schenk","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib45","first-page":"545","article-title":"kappa-Opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine","volume":"276","author":"Shippenberg","year":"1996","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib46","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1749-6632.2001.tb03558.x","article-title":"Modulation of the behavioral and neurochemical effects of psychostimulants by kappa-opioid receptor systems","volume":"937","author":"Shippenberg","year":"2001","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib47","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0301-0082(96)00045-7","article-title":"Dynorphin and epilepsy","volume":"50","author":"Simonato","year":"1996","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib48","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1006\/exnr.2001.7696","article-title":"Spatiotemporal analysis of Fos expression associated with cocaine- and PTZ-induced seizures in prenatally cocaine-treated rats","volume":"170","author":"Snyder-Keller","year":"2001","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib49","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.tips.2003.12.010","article-title":"Epilepsy, CNS viral injury and dynorphin","volume":"25","author":"Solbrig","year":"2004","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib50","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/brain\/awl008","article-title":"Kappa opioid control of seizures produced by a virus in an animal model","volume":"129","author":"Solbrig","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib51","first-page":"607","article-title":"Modulation of the discriminative stimulus effects of cocaine by mu and kappa opioids","volume":"261","author":"Spealman","year":"1992","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib52","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00008877-199402000-00003","article-title":"Opioid modulation of the discriminative stimulus effects of cocaine: comparison of micro, kappa and delta agonists in squirrel monkeys discriminating low doses of cocaine","volume":"5","author":"Spealman","year":"1994","journal-title":"Behavioral Pharmacology"},{"year":"1987","series-title":"Manual of Pharmacologic Calculations with Computer Programs","author":"Tallarida","key":"10.1016\/j.neuropharm.2006.10.007_bib53"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib54","doi-asserted-by":"crossref","first-page":"9333","DOI":"10.1523\/JNEUROSCI.20-24-09333.2000","article-title":"Kappa-opioid receptor activation modifies dopamine uptake in the nucleus accumbens and opposes the effects of cocaine","volume":"20","author":"Thompson","year":"2000","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib55","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/0024-3205(90)90501-H","article-title":"PD117302, a selective non-peptide opioid kappa agonist, protects against NMDA and maximal electroshock convulsions in rats","volume":"46","author":"Tortella","year":"1990","journal-title":"Life Sciences"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib56","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s002130000424","article-title":"Dissociable effects of the kappa-opioid receptor agonists bremazocine, U69593, and U50488H on locomotor activity and long-term behavioral sensitization induced by amphetamine and cocaine","volume":"150","author":"Vanderschuren","year":"2000","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib57","first-page":"542","article-title":"U-54494A: a unique anticonvulsant related to kappa opioid agonists","volume":"243","author":"VonVoigtlander","year":"1987","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib58","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1523\/JNEUROSCI.12-01-00132.1992","article-title":"Kappa-opioids decrease excitatory transmission in the dentate gyrus of the guinea pig hippocampus","volume":"12","author":"Wagner","year":"1992","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib59","first-page":"355","article-title":"Sigma receptors: biology and function","volume":"42","author":"Walker","year":"1990","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib60","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1046\/j.1528-1157.43.s.5.1.x","article-title":"Short-term plasticity of hippocampal neuropeptides and neuronal circuitry in experimental status epilepticus","author":"Wasterlain","year":"2002","journal-title":"Epilepsia 43 (Suppl. 5)"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib61","first-page":"273","article-title":"Carbamazepine retards the development of cocaine-kindled seizures but not sensitization to cocaine-induced hyperactivity","volume":"3","author":"Weiss","year":"1990","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib62","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/0024-3205(89)90366-4","article-title":"Lethal effects of cocaine are reduced by the dopamine-1 receptor antagonist SCH 23390 but not by haloperidol","volume":"44","author":"Witkin","year":"1989","journal-title":"Life Sciences"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib63","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0376-8716(91)90037-Y","article-title":"The partial opioid agonist, buprenorphine, protects against lethal effects of cocaine","volume":"27","author":"Witkin","year":"1991","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib64","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0022-3565(24)38191-1","article-title":"Anticonvulsant efficacy of N-methyl-d-aspartate antagonists against convulsions induced by cocaine","volume":"289","author":"Witkin","year":"1999","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib65","first-page":"266","article-title":"Role of dopamine D1 receptors in the lethal effects of cocaine and a quaternary methiodide analog","volume":"267","author":"Witkin","year":"1993","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2006.10.007_bib66","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0006-8993(00)02096-5","article-title":"Effects of differential modulation of mu-, delta- and kappa-opioid systems on bicuculline-induced convulsions in the mouse","volume":"862","author":"Yajima","year":"2000","journal-title":"Brain Research"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390806003613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390806003613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,12]],"date-time":"2025-01-12T05:45:09Z","timestamp":1736660709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390806003613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0028390806003613"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2006.10.007","relation":{},"ISSN":["0028-3908"],"issn-type":[{"type":"print","value":"0028-3908"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}